Authors:
FETSCH PA
FETSCH JF
MARINCOLA FM
TRAVIS W
BATTS KP
ABATI A
Citation: Pa. Fetsch et al., COMPARISON OF MELANOMA ANTIGEN RECOGNIZED BY T-CELLS (MART-1) TO HMB-45 - ADDITIONAL EVIDENCE TO SUPPORT A COMMON LINEAGE FOR ANGIOMYOLIPOMA, LYMPHANGIOMYOMATOSIS, AND CLEAR-CELL SUGAR TUMOR, Modern pathology, 11(8), 1998, pp. 699-703
Authors:
FETSCH PA
MARINCOLA F
FILIE A
HIJAZI Y
ABATI A
Citation: Pa. Fetsch et al., MELANOMA-ASSOCIATED ANTIGEN RECOGNIZED BY T-CELLS (MART-1) - THE ADVENT OF A PREFERRED IMMUNOHISTOCHEMICAL ANTIBODY FOR THE DIAGNOSIS OF METASTATIC MALIGNANT-MELANOMA (MMM) IN FINE-NEEDLE ASPIRATIONS (FNA), Modern pathology, 11(1), 1998, pp. 37-37
Citation: Pa. Fetsch et al., UTILITY OF THE ANTIBODIES CA-19-9, HBME-1, AND THROMBOMODULIN IN THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA AND ADENOCARCINOMA IN CYTOLOGY, CANCER CYTOPATHOLOGY, 84(2), 1998, pp. 101-108
Citation: Pa. Fetsch et al., IMMUNOCYTOCHEMICAL DETECTION OF MART-1 IN FRESH AND PARAFFIN-EMBEDDEDMALIGNANT MELANOMAS, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 60-64
Authors:
FETSCH PA
FETSCH JF
MARINCOLA FM
TRAVIS W
BATTS K
ABATI A
Citation: Pa. Fetsch et al., COMPARISON OF MELANOMA-ASSOCIATED MEMBRANE ANTIGEN, MART-1, TO HMB-45- FURTHER EVIDENCE TO SUPPORT A COMMON LINEAGE FOR ANGIOMYOLIPOMA (AML), LYMPHANGIOMYOMATOSIS (LAM) AND CLEAR-CELL SUGAR TUMOR, Laboratory investigation, 76(1), 1997, pp. 36-36
Citation: Pa. Fetsch et al., ANALYSIS OF MELANOMA-ASSOCIATED ANTIGEN, MART-1, IN NORMAL-TISSUES AND IN SELECTED NONMELANOMATOUS NEOPLASMS, Laboratory investigation, 76(1), 1997, pp. 235-235
Authors:
TOLCHER AW
COWAN KH
SOLOMON D
OGNIBENE F
GOLDSPIEL B
CHANG R
NOONE MH
DENICOFF AM
BARNES CS
GOSSARD MR
FETSCH PA
BERG SL
BALIS FM
VENZON DJ
OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1173-1184
Citation: A. Abati et Pa. Fetsch, OV632 AS A POSSIBLE MARKER FOR MALIGNANT MESOTHELIOMA - HIGH EXPECTATIONS - LOW SPECIFICITY, Diagnostic cytopathology, 12(1), 1995, pp. 81-82